We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Suggests Statistical Strategies for Mitigating Data Loss During the Pandemic
FDA Suggests Statistical Strategies for Mitigating Data Loss During the Pandemic
Sponsors of trials impacted by the COVID-19 pandemic have several statistical analysis options for mitigating the effect of missing data, according to the FDA.